<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Replicel Life Sciences Inc. — News on 6ix</title>
<link>https://6ix.com/company/replicel-life-sciences-inc</link>
<description>Latest news and press releases for Replicel Life Sciences Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 05 Aug 2020 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/replicel-life-sciences-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b6e278dffbe2df114490.webp</url>
<title>Replicel Life Sciences Inc.</title>
<link>https://6ix.com/company/replicel-life-sciences-inc</link>
</image>
<item>
<title>BCSC Revocation of Cease Trade Order</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/bcsc-revocation-of-cease-trade-order-12</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/bcsc-revocation-of-cease-trade-order-12</guid>
<pubDate>Wed, 05 Aug 2020 04:00:00 GMT</pubDate>
<description>BCSC Revocation of Cease Trade Order.</description>
</item>
<item>
<title>BCSC Cease Trade Order</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/bcsc-cease-trade-order-46</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/bcsc-cease-trade-order-46</guid>
<pubDate>Wed, 17 Jun 2020 04:00:00 GMT</pubDate>
<description>BCSC Cease Trade Order.</description>
</item>
<item>
<title>RepliCel Announces its Incoming Board of Directors</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-announces-its-incoming-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-announces-its-incoming-board-of-directors</guid>
<pubDate>Mon, 23 Dec 2019 11:14:41 GMT</pubDate>
<description>RepliCel Announces its Incoming Board of Directors.</description>
</item>
<item>
<title>RepliCel Provides 2019 Year-End Update</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-provides-2019-year-end-update</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-provides-2019-year-end-update</guid>
<pubDate>Tue, 26 Nov 2019 11:13:11 GMT</pubDate>
<description>RepliCel Provides 2019 Year-End Update.</description>
</item>
<item>
<title>Clinical Data Published from RepliCel's Skin Rejuvenation Study</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/clinical-data-published-from-replicels-skin-rejuvenation-study</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/clinical-data-published-from-replicels-skin-rejuvenation-study</guid>
<pubDate>Tue, 24 Sep 2019 10:10:14 GMT</pubDate>
<description>Clinical Data Published from RepliCel's Skin Rejuvenation Study.</description>
</item>
<item>
<title>RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicels-partner-yofoto-china-health-unveils-its-inaugural-cell-therapy-manufacturing-facility-in-china</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicels-partner-yofoto-china-health-unveils-its-inaugural-cell-therapy-manufacturing-facility-in-china</guid>
<pubDate>Tue, 10 Sep 2019 10:19:11 GMT</pubDate>
<description>RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China.</description>
</item>
<item>
<title>RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-retains-dermatology-sales-and-marketing-executive-to-guide-the-global-commercial-strategy-for-its-automated-dermal-injector</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-retains-dermatology-sales-and-marketing-executive-to-guide-the-global-commercial-strategy-for-its-automated-dermal-injector</guid>
<pubDate>Thu, 29 Aug 2019 10:16:10 GMT</pubDate>
<description>RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector.</description>
</item>
<item>
<title>RepliCel Secures Several New Patents for its Regenerative Medicine Technologies</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-secures-several-new-patents-for-its-regenerative-medicine-technologies</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-secures-several-new-patents-for-its-regenerative-medicine-technologies</guid>
<pubDate>Tue, 16 Apr 2019 13:27:25 GMT</pubDate>
<description>RepliCel Secures Several New Patents for its Regenerative Medicine Technologies.</description>
</item>
<item>
<title>RepliCel's Licensee Building Momentum in China with Facility and Team</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicels-licensee-building-momentum-in-china-with-facility-and-team</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicels-licensee-building-momentum-in-china-with-facility-and-team</guid>
<pubDate>Tue, 26 Mar 2019 10:02:13 GMT</pubDate>
<description>RepliCel's Licensee Building Momentum in China with Facility and Team.</description>
</item>
<item>
<title>RepliCel Reignites its First-in-Japan Strategy</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-reignites-its-first-in-japan-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-reignites-its-first-in-japan-strategy</guid>
<pubDate>Tue, 19 Mar 2019 10:02:11 GMT</pubDate>
<description>RepliCel Reignites its First-in-Japan Strategy.</description>
</item>
<item>
<title>RepliCel CEO Provides 2019 Shareholder Update</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-2019-shareholder-update</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-2019-shareholder-update</guid>
<pubDate>Tue, 05 Mar 2019 11:04:45 GMT</pubDate>
<description>RepliCel CEO Provides 2019 Shareholder Update.</description>
</item>
<item>
<title>RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-appoints-head-of-clinical-and-regulatory-affairs</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-appoints-head-of-clinical-and-regulatory-affairs</guid>
<pubDate>Tue, 06 Nov 2018 11:09:11 GMT</pubDate>
<description>RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs.</description>
</item>
<item>
<title>RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-announces-federal-grant-funding-for-collaboration-with-the-university-of-victoria-canada</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-announces-federal-grant-funding-for-collaboration-with-the-university-of-victoria-canada</guid>
<pubDate>Thu, 18 Oct 2018 10:07:46 GMT</pubDate>
<description>RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada.</description>
</item>
<item>
<title>RepliCel Life Sciences Appoints New Chief Financial Officer</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-appoints-new-chief-financial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-appoints-new-chief-financial-officer</guid>
<pubDate>Wed, 17 Oct 2018 10:07:45 GMT</pubDate>
<description>RepliCel Life Sciences Appoints New Chief Financial Officer.</description>
</item>
<item>
<title>RepliCel CEO Provides Updated Outlook</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-updated-outlook</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-updated-outlook</guid>
<pubDate>Mon, 15 Oct 2018 10:07:42 GMT</pubDate>
<description>RepliCel CEO Provides Updated Outlook.</description>
</item>
<item>
<title>RepliCel Life Sciences Completes Financing with YOFOTO (China) Health</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-completes-financing-with-yofoto-china-health</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-completes-financing-with-yofoto-china-health</guid>
<pubDate>Thu, 11 Oct 2018 10:07:42 GMT</pubDate>
<description>RepliCel Life Sciences Completes Financing with YOFOTO (China) Health.</description>
</item>
<item>
<title>RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-and-yofoto-china-health-obtain-all-approvals-needed-to-complete-investment</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-and-yofoto-china-health-obtain-all-approvals-needed-to-complete-investment</guid>
<pubDate>Mon, 24 Sep 2018 10:06:15 GMT</pubDate>
<description>RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment.</description>
</item>
<item>
<title>RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-announces-signed-licensing-and-co-development-deal-for-greater-china</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-announces-signed-licensing-and-co-development-deal-for-greater-china</guid>
<pubDate>Wed, 11 Jul 2018 10:02:44 GMT</pubDate>
<description>RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China.</description>
</item>
<item>
<title>RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-now-finalizing-its-strategic-investment-partnership-with-china-based-yofoto</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-life-sciences-now-finalizing-its-strategic-investment-partnership-with-china-based-yofoto</guid>
<pubDate>Wed, 02 May 2018 10:00:49 GMT</pubDate>
<description>RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO.</description>
</item>
<item>
<title>RepliCel CEO Provides 2018 Shareholder Update</title>
<link>https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-2018-shareholder-update</link>
<guid isPermaLink="true">https://6ix.com/company/replicel-life-sciences-inc/news/replicel-ceo-provides-2018-shareholder-update</guid>
<pubDate>Thu, 25 Jan 2018 11:01:44 GMT</pubDate>
<description>RepliCel CEO Provides 2018 Shareholder Update.</description>
</item>
</channel>
</rss>